In this regard, a recently published study links inhibition of ZMPSTE24 activity by protease treatment in HIV patients with increased levels of premature prelamin A mediating myocardial inflammation and HIV-associated cardiomyopathy [17]. This evidence concerns the gene ZMPSTE24 and cardiomyopathy.